Financial reports
ARS
2023 FY
Annual report to shareholders
22 Mar 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
24 Mar 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
31 Oct 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Departure of Directors or Certain Officers
15 Mar 24
8-K
Janus Henderson Group plc Reports Fourth Quarter and Full-Year 2023 Results
1 Feb 24
8-K
Janus Henderson Group plc Reports Third Quarter 2023 Results
1 Nov 23
8-K
Departure of Directors or Certain Officers
18 Aug 23
8-K
Janus Henderson Group plc Reports Second Quarter 2023 Results
2 Aug 23
8-K
Entry into a Material Definitive Agreement
5 Jul 23
8-K
Janus Henderson Announces Changes to Board of Directors
2 Jun 23
8-K
Janus Henderson Announces Appointment of Leslie F. Seidman to Board of Directors
31 May 23
8-K
Submission of Matters to a Vote of Security Holders
5 May 23
8-K
Janus Henderson Group plc Reports First Quarter 2023 Results
3 May 23
Registration and prospectus
S-8
Registration of securities for employees
16 Jun 22
424B5
Prospectus supplement for primary offering
5 Feb 21
FWP
Free writing prospectus
4 Feb 21
424B3
Prospectus supplement
4 Feb 21
S-3ASR
Automatic shelf registration
4 Feb 21
S-8
Registration of securities for employees
27 Feb 20
POS AM
Prospectus update (post-effective amendment)
29 Jun 17
S-8
Registration of securities for employees
31 May 17
8-A12B
Registration of securities on exchange
25 May 17
424B3
Prospectus supplement
19 Apr 17
Proxies
DEFA14A
Additional proxy soliciting materials
22 Mar 24
DEF 14A
Definitive proxy
22 Mar 24
PRE 14A
Preliminary proxy
28 Feb 24
DEFA14A
Additional proxy soliciting materials
24 Mar 23
DEFA14A
Additional proxy soliciting materials
24 Mar 23
DEF 14A
Definitive proxy
24 Mar 23
PRE 14A
Preliminary proxy
1 Mar 23
DEFA14A
Additional proxy soliciting materials
24 Mar 22
DEF 14A
Definitive proxy
24 Mar 22
DEFA14A
Additional proxy soliciting materials
23 Mar 22
Other
UPLOAD
Letter from SEC
5 Nov 19
CORRESP
Correspondence with SEC
28 Jun 19
UPLOAD
Letter from SEC
14 Jun 19
EFFECT
Notice of effectiveness
5 Jul 17
CERTNYS
Certification of approval for NYSE listing
25 May 17
EFFECT
Notice of effectiveness
21 Mar 17
CORRESP
Correspondence with SEC
20 Mar 17
UPLOAD
Letter from SEC
13 Mar 17
UPLOAD
Letter from SEC
27 Feb 17
UPLOAD
Letter from SEC
6 Feb 17
Ownership
3
STEVEN SABA
12 Apr 24
SC 13G
ARCA biopharma, Inc.
11 Apr 24
SC 13G/A
Beauty Health Co
5 Apr 24
SC 13G
PRECISION BIOSCIENCES INC
11 Mar 24
SC 13G
Applied Therapeutics Inc.
8 Mar 24
4
Brennan A. Hughes
7 Mar 24
4
MICHELLE ROSENBERG
4 Mar 24
4
Brennan A. Hughes
4 Mar 24
4
Ali Dibadj
4 Mar 24
4
GEORGINA FOGO
4 Mar 24